In March 2025, the company introduced new designs for the immediate-to-consumer supplying of its Wegovy weight loss drug. The company proven a different pharmacy, called NovoCare, which might demand buyers $499 a month for use of the drug, lower than fifty percent the cost of the drug by means of other pharmaceutical distribution networks.[fifty th